__NUXT_JSONP__("/drugs/Daclizumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"152923-56-3",chebiId:b,chemicalFormula:b,definition:"A recombinant monoclonal antibody interleukin-2 receptor antagonist.  Daclizumab binds specifically to the alpha subunit of the human interleukin-2 (IL-2) receptor expressed on the surface of activated lymphocytes in vivo, thereby inhibiting IL-2 binding and IL-2-mediated lymphocyte activation, a critical cellular immune response pathway.",fdaUniiCode:"CUJ2MVI71Y",identifier:"C1569",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C20401","C574"],synonyms:["Anti-Tac","Anti-Tac Humanized Monoclonal Antibody","Anti-Tac Monoclonal Antibody","DACLIZUMAB","Dacliximab",a,"Humanized Anti-Tac Monoclonal Antibody","Monoclonal Antibody Anti-Tac","Zenapax","daclizumab"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FDaclizumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Daclizumab","","2021-10-30T13:34:32.733Z")));